These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 30047220)

  • 1. Intensive multidisciplinary weight management in patients with type 1 diabetes and obesity: A one-year retrospective matched cohort study.
    Mottalib A; Tomah S; Hafida S; Elseaidy T; Kasetty M; Ashrafzadeh S; Hamdy O
    Diabetes Obes Metab; 2019 Jan; 21(1):37-42. PubMed ID: 30047220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.
    Simonson DC; Halperin F; Foster K; Vernon A; Goldfine AB
    Diabetes Care; 2018 Apr; 41(4):670-679. PubMed ID: 29432125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary intensive lifestyle intervention improves markers of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes and obesity: a retrospective matched-cohort study.
    Tomah S; Salah T; Al-Badri M; Dhaver S; Gardner H; Tasabehji MW; Hamdy O
    Clin Diabetes Endocrinol; 2023 Apr; 9(1):3. PubMed ID: 37046323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustable Gastric Band Surgery or Medical Management in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Ding SA; Simonson DC; Wewalka M; Halperin F; Foster K; Goebel-Fabbri A; Hamdy O; Clancy K; Lautz D; Vernon A; Goldfine AB
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2546-56. PubMed ID: 25909333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial.
    Holland-Carter L; Tuerk PW; Wadden TA; Fujioka KN; Becker LE; Miller-Kovach K; Hollander PL; Garvey WT; Weiss D; Rubino DM; Kushner RF; Malcolm RJ; Raum WJ; Hermayer KL; Veliko JL; Rost SL; Sora ND; Salyer JL; O'Neil PM
    J Diabetes Complications; 2017 May; 31(5):891-897. PubMed ID: 28319001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dairy Consumption and Cardiometabolic Risk Factors in Patients with Type 2 Diabetes and Overweight or Obesity during Intensive Multidisciplinary Weight Management: A Prospective Observational Study.
    Tomah S; Eldib AH; Tasabehji MW; Mitri J; Salsberg V; Al-Badri MR; Gardner H; Hamdy O
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32498266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non-interventional outcomes at 3 years.
    Botha S; Forde L; MacNaughton S; Shearer R; Lindsay R; Sattar N; Morrison D; Welsh P; Logue J
    Diabetes Obes Metab; 2018 Apr; 20(4):879-888. PubMed ID: 29178635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes.
    Lih A; Pereira L; Bishay RH; Zang J; Omari A; Atlantis E; Kormas N
    J Diabetes Res; 2015; 2015():729567. PubMed ID: 25950007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R; Cowx M; Poole C; McEwan P; Morgan C; Walker M
    Curr Med Res Opin; 2005 Nov; 21(11):1885-90. PubMed ID: 16307710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan.
    Muramoto A; Matsushita M; Kato A; Yamamoto N; Koike G; Nakamura M; Numata T; Tamakoshi A; Tsushita K
    Obes Res Clin Pract; 2014; 8(5):e466-75. PubMed ID: 25263836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should metabolic surgery be offered in morbidly obese patients with type I diabetes?
    Robert M; Belanger P; Hould FS; Marceau S; Tchernof A; Biertho L
    Surg Obes Relat Dis; 2015; 11(4):798-805. PubMed ID: 25868828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Programme: A randomized clinical trial.
    Liu H; Wang L; Zhang S; Leng J; Li N; Li W; Wang J; Tian H; Qi L; Yang X; Yu Z; Tuomilehto J; Hu G
    Diabetes Obes Metab; 2018 May; 20(5):1246-1255. PubMed ID: 29360237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.
    Kaukua JK; Pekkarinen TA; Rissanen AM
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):600-5. PubMed ID: 14770192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight outcomes audit in 1.3 million adults during their first 3 months' attendance in a commercial weight management programme.
    Stubbs RJ; Morris L; Pallister C; Horgan G; Lavin JH
    BMC Public Health; 2015 Sep; 15():882. PubMed ID: 26359180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results.
    Igudesman D; Crandell J; Corbin KD; Zaharieva DP; Addala A; Thomas JM; Casu A; Kirkman MS; Pokaprakarn T; Riddell MC; Burger K; Pratley RE; Kosorok MR; Maahs DM; Mayer-Davis EJ;
    Diabetes Obes Metab; 2023 Mar; 25(3):688-699. PubMed ID: 36314293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of long term weight loss maintenance in patients at high risk of type 2 diabetes participating in a lifestyle intervention program in primary health care: The DE-PLAN study.
    Gilis-Januszewska A; Barengo NC; Lindström J; Wójtowicz E; Acosta T; Tuomilehto J; Schwarz PEH; Piwońska-Solska B; Szybiński Z; Windak A; Hubalewska-Dydejczyk A
    PLoS One; 2018; 13(3):e0194589. PubMed ID: 29570724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of a portion-controlled meal replacement program for weight loss in adults with and without diabetes/high blood sugar.
    Coleman CD; Kiel JR; Mitola AH; Arterburn LM
    Nutr Diabetes; 2017 Jul; 7(7):e284. PubMed ID: 28692020
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.